Effect of potassium canrenoate on cardiac functions and (Na +  + K + )-activated ATPase.
D000251:Adenosine Triphosphatases / Q000378:metabolism*; D000818:Animals; D001145:Arrhythmias, Cardiac / Q000139:chemically induced; D003326:Coronary Circulation / Q000187:drug effects; D004232:Diuretics / Q000494:pharmacology*; D004789:Enzyme Activation / Q000187:drug effects; D005260:Female; D006168:Guinea Pigs; D006321:Heart / Q000187:drug effects*; D006339:Heart Rate / Q000187:drug effects; D006914:Hydroxysteroids / Q000494:pharmacology; D007664:Ketosteroids / Q000494:pharmacology; D008297:Male; D009206:Myocardium / Q000201:enzymology*; D010042:Ouabain / Q000494:pharmacology; D011188:Potassium; D011245:Pregnadienes / Q000494:pharmacology*; D011422:Propionates / Q000494:pharmacology; D051381:Rats; D012964:Sodium
D004232:Diuretics; D006914:Hydroxysteroids; D007664:Ketosteroids; D011245:Pregnadienes; D011422:Propionates; D010042:Ouabain; D012964:Sodium; D000251:Adenosine Triphosphatases; D011188:Potassium